Embase supports medical device development and post-market surveillance
Information found in the biomedical literature strengthens every stage of the medical device life cycle, from concept and design through clinical trials to release and reimbursement. Regulatory authorities require medical device companies to screen the biomedical literature during the approval process and for post-market surveillance. Embase includes unique medical device information and indexing, making it an indispensable resource.
- Comprehensive and up-to-date information, with over 30 million records from more than 8,500 journals and 5,500 conferences
- The Embase thesaurus, Emtree, includes over 3,000 medical device terms
- A dedicated medical device search form and device subheadings that show relationships to related terms (e.g., adverse device events, device comparison, device economics)
- Indexing of device trade names and, manufacturer names
The Test to Target a Drug
A companion diagnostic can make or break the market entry of a precision medicine. See how Embase supports medical device development and post-market surveillance.
Learn how biomedical literature supports manufacturers throughout medical device development and post-market surveillance.
Embase supports medical device development and post-market surveillance.
Embase Fact Sheet (PDF, 459.9 KB)
Medical Device Guidelines are changing
The Medical Device Guideline (MEDDEV 2.7/1) for Clinical Evaluation Reports (CER) has been revised. See how Embase supports the systematic literature reviews critical for CER.
Read the Fact Sheet (PDF, 431kb)
I have an alert compiled to send me the newest product-related articles at the beginning of each month. This email helps me to be aware of potential hot topic requests.
Embase is an essential resource for post-market monitoring of medical devices—I can't imagine doing that kind of safety monitoring without it.
Learn How Elsevier supports post-market surveillance of medical devices
Get the whole story on how Elsevier helps pharmaceutical and medical device manufacturers stay compliant with regulatory requirements for adverse event reporting